잠시만 기다려 주세요. 로딩중입니다.

Clinical outcomes of adjuvant radiation therapy and prognostic factors in early stage uterine cervical cancer

Radiation Oncology Journal
2015년 33권 2호 p.126 ~ p.133
 ( Kim Hyun-jung ) - Yonsei University College of Medicine Yonsei Cancer Center Department of Radiation Oncology

 ( Rhee Woo-Joong ) - Yonsei University College of Medicine Department of Radiation Oncology
 ( Choi Seo-Hee ) - Yonsei University College of Medicine Yonsei Cancer Center Department of Radiation Oncology
 ( Nam Eun-Ji ) - Yonsei University College of Medicine Yonsei Cancer Center Department of Obstetrics and Gynecology
 ( Kim Sang-Wun ) - Yonsei University College of Medicine Yonsei Cancer Center Department of Obstetrics and Gynecology
 ( Kim Sung-Hoon ) - Yonsei University College of Medicine Yonsei Cancer Center Department of Obstetrics and Gynecology
 ( Kim Young-Tae ) - Yonsei University College of Medicine Yonsei Cancer Center Department of Obstetrics and Gynecology
 ( Kim Gwi-Eon ) - Yonsei University College of Medicine Yonsei Cancer Hospital Departments of Radiation Oncology
 ( Kim Yong-Bae ) - Yonsei University College of Medicine Yonsei Cancer Center Department of Radiation Oncology

Abstract

Purpose: To evaluate the outcomes of adjuvant radiotherapy (RT) and to analyze prognostic factors of survival in the International Federation of Gynecology and Obstetrics (FIGO) IB-IIA uterine cervical cancer.

Materials and Methods: We retrospectively reviewed the medical records of 148 patients with FIGO IB-IIA uterine cervical cancer who underwent surgery followed by adjuvant RT at the Yonsei Cancer Center between June 1997 and December 2011. Adjuvant radiotherapy was delivered to the whole pelvis or an extended field with or without brachytherapy. Among all patients, 57 (38.5%) received adjuvant chemotherapy either concurrently or sequentially. To analyze prognostic factors, we assessed clinicopathologic variables and metabolic parameters measured on preoperative 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT). To evaluate the predictive performance of metabolic parameters, receiver operating characteristic curve analysis was used. Overall survival (OS) and disease-free survival (DFS) were analyzed by the Kaplan-Meier method.

Results: The median follow-up period was 63.2 months (range, 2.7 to 206.8 months). Locoregional recurrence alone occurred in 6 patients, while distant metastasis was present in 16 patients, including 2 patients with simultaneous regional failure. The 5-year and 10-year OSs were 87.0% and 85.4%, respectively. The 5-year and 10-year DFSs were 83.8% and 82.5%, respectively. In multivariate analysis, pathologic type and tumor size were shown to be significant prognostic factors associated with both DFS and OS. In subset analysis of 40 patients who underwent preoperative PET/CT, total lesion glycolysis was shown to be the most significant prognostic factor among the clinicopathologic variables and metabolic parameters for DFS.

Conclusion: Our results demonstrated that adjuvant RT following hysterectomy effectively improves local control. From the subset analysis of preoperative PET/CT, we can consider that metabolic parameters may hold prognostic significance in early uterine cervical cancer patients. More effective systemic treatments might be needed to reduce distant metastasis in these patients.

키워드

원문 및 링크아웃 정보
등재저널 정보
학술진흥재단(KCI) KoreaMed 
주제코드
주제명
(Target field)
연구대상
(Population)
연구참여
(Sample size)
대상성별
(Gender)
질병특성
(Condition Category)
연구환경
(Setting)
연구설계
(Study Design)
연구기간
(Period)
중재방법
(Intervention Type)
중재명칭
(Intervention Name)
키워드
(Keyword)
유효성결과
(Recomendation)
연구비지원
(Fund Source)
근거수준평가
(Evidence Hierarchy)
출판년도
(Year)
참여저자수
(Authors)
대표저자
(1st Authors)
Doi
KCD코드
ICD 03
건강보험코드